Navigation Links
UC scientists awarded $1.7 million for low back pain research

CINCINNATIThe National Institute of Neurological Disorders and Stroke has awarded $1.7 million to University of Cincinnati (UC) anesthesiology researchers to study a condition that costs Americans $50 billion a yearlow back pain.

Back pain is the leading cause of disability in Americans younger than 45 years old and is experienced by 50 to 80 percent of adults at some point in their lives. Back pain becomes chronic if it persists for more than three months and the cause can sometimes be difficult to determine.

The UC researchers are focusing their five-year study on inflammation and how its effects on sensory neurons in the low back cause persistent chronic pain.

The team, led by Jun-Ming Zhang, MD, director of UCs Pain Research Center, believes small molecules called chemokines are key factors in the development of pain. Chemokines are a family of small cytokineschemical messenger molecules used by immune and nerve cells to communicate with other cells.

If we can determine the role these chemokines play in the development of back pain we can hopefully develop better medications to treat the problem, says Zhang.

Zhang says acute (short-term) pain can actually be beneficial. Acute pain responses to potentially dangerous stimulilike the neural circuitry that tells you to pull your hand away from a hot stoveare essential for survival, says Zhang.

But when pain becomes chronic, it serves no useful purpose, he says, and often affects a persons quality of life.

Back pain can be caused by physical trauma such as a sports injury, lifting heavy items or from a car accident, Zhang explains. For others, medical conditions such as a herniated disc cause pain. But many people experience back pain for no apparent reason.

When a patient goes to the doctor for low back pain, they may undergo an MRI or an X-ray. Sometimes these tests show anatomical reasons for the pain such as a herniated disc. But for some patients, tests dont show any physical evidence for why they are experiencing low back pain, he says.

Zhang adds that the lack of physical evidence can be very frustrating for patients and make it more difficult for doctors to help a patient effectively manage their pain through medication and other treatment therapies.

Thats why we hope to identify specific molecules that contribute to low back pain development. Our goal is to develop a non-opiod analgesic targeting those molecules to alleviate pain, says Zhang.

In previous research, Zhang and his team, including Judith Strong, PhD, co-investigator for the new study, found that pain-sensing neurons can become abnormally sensitive or fire spontaneously in the absence of stimuli. This early spontaneous activity plays a key role in setting up the pathological pain state.

We found that by blocking the early spontaneous activity of an injured nerve we can completely prevent the development of chronic pain. This technique could be extremely useful for combat nerve injuries and amputations that often lead chronic pain, he says.

In the new study, the team will explore how inflammation may contribute to the development of low back pain by intentionally causing this abnormal neuronal firing.


Contact: Jamie Kaun
University of Cincinnati

Related medicine news :

1. Scientists explore factors contributing to DNA mutations
2. CIHR news: U of S scientists find plant gene that affects stress resistance
3. Scientists use nanomaterials to localize and control drug delivery
4. Scientists identify genes linked to lupus in women
5. Scripps research scientists find new genetic mutation that halts the development of lupus
6. Jefferson scientists uncover role of cancer stem cell marker: controlling gene expression
7. Jefferson scientists find protein helps pancreatic cancer cells evade immune system and spread
8. 2 Hebrew University scientists awarded Wolf Prizes
9. UCLA scientists restore walking after spinal cord injury
10. Scientists Report Refinements to Brain Surgery
11. Jefferson scientists find protein potential drug target for treatment-resistant prostate cancer
Post Your Comments:
(Date:10/13/2017)... ... 2017 , ... Ellevate Network, the leading network for professional women, brought together ... equality at their inaugural Summit in New York City in June. The event was ... of over 3 million. To watch the Mobilize Women video, click here . ...
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of ... Philippines. “The Journey: From the Mountains to the Mission Field” is the creation of ... taught all ages and currently teaches a class of ladies at her church, which ...
(Date:10/12/2017)... WAUSAU, Wis. (PRWEB) , ... October 12, 2017 ... ... formulated standard products to meet the demand of today’s consumer and regulatory authorities ... team of probiotic experts and tested to meet the highest standard. , ...
(Date:10/12/2017)... ... October 12, 2017 , ... ... Restoration, has recently contributed a medical article to the newly revamped Cosmetic ... Mohebi’s article spotlights the hair transplant procedure known as Follicular Unit Extraction ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... the nation's first interactive health literacy software tool, and the Cancer Patient Education ... of cancer patient education, today announce a new strategic alliance. , As ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... , Oct. 4, 2017  South Korean-based healthcare product ... training aide "cprCUBE" on Kickstarter. The device will educate ... cardiac arrests with better efficiency compared to the dated ... real-time feedback on efficacy of the compression for a ... has a goal to raise $5,000. ...
(Date:10/4/2017)... Mass. , Oct. 4, 2017 ... of single-use, self-contained, illuminating medical devices, today announced ... National Health Surveillance Agency (or Agência Nacional de ... The first single-use, cordless surgical retractor with integrated ... provides optimal access, illumination and exposure of a ...
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
Breaking Medicine Technology: